Skip to main content
. 2019 Jun 17;9:504. doi: 10.3389/fonc.2019.00504

Table 1.

Patient demography.

Subject category n (%)
Total 106 (100)
    Benign 9 (8.5)
    Renal cell carcinoma (RCC) 97 (91.5)
Age Median (range)
    Total 55.6 (28–74)
    Men 56.1 (31–74)
    Women 54.2 (28–70)
Gender
    Men 79 (74.5)
    Women 27 (25.5)
Location
    Right kidney 43 (40.6)
    Left kidney 62 (58.5)
    Both 1 (0.9)
Benign subtype
    Renal cyst 2 (1.8)
    Renal oncocytoma 1 (0.9)
    Angiomyolipoma 5 (4.7)
    Nephrotuberculosis 1 (0.9)
RCC subtype
    Clear cell renal cell carcinoma (ccRCC) 84 (79.2)
    Papillary renal cell carcinoma (pRCC) 2 (1.8)
    Chromophobe renal cell carcinoma (chRCC) 3 (2.8)
    Xp11.2 translocation renal cell carcinoma (Xp11_RCC) 3 (2.8)
    Othersa 5 (4.7)
RCC subtype Stage I/II/III/IVb
    all RCC 62/4/17/14
    ccRCC 58/3/12/11
    pRCC 2/0/0/0
    chRCC 2/0/1/0
    Xp11_RCC 0/0/3/0
    othersa 0/1/1/3
Furman's grade
    I-II 56 (57.7)
    III-IV 35 (36.1)
    NA 6 (6.2)
Concentration of preoperative plasma C-reactive protein, mg/dL
    ≦0.6 (normal) 60 (56.6)
    >0.6 (high) 23 (21.7)
    NA 23 (21.7)
Concentration of preoperative plasma fibrinogen, g/L
    ≧4 (normal) 64 (60.4)
    >4 (high) 16 (15.1)
    NA 26 (24.5)
a

Others: two types of pathological subtypes coexisting in one patient or unoperated patients with an undetermined pathological subtype.

b

Stage I/II/III/IV: number of patients with different RCC subtypes in different clinical stages.